Dexcel Pharma Technologies Ltd. - 10%+ Owner at Protalix BioTherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
PLX on NYSE
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Dexcel Pharma Technologies Ltd. since 12/22/2023

Holdings reported by Dexcel Pharma Technologies Ltd. for Protalix BioTherapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 3.64M $5.13M $1.41 Jun 3, 2021 Direct

Transactions reported by Dexcel Pharma Technologies Ltd. for Protalix BioTherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.